Herman Yue devises sophisticated intellectual property solutions for clients, particularly within the life sciences and biopharmaceutical space.
Dr. Yue leverages his molecular biology expertise and broad-ranging experience across all phases of patent litigation to help clients — ranging from cutting-edge startups to Fortune 50 industry leaders — advance highly technical legal solutions that address:
- Patent infringement actions
- Litigation under the Biologics Price Competition and Innovation Act (BPCIA) and Hatch-Waxman Act
- Inter partes review proceedings before the US Patent and Trademark Office (USPTO)
- Cross-border proceedings involving patent offices and courts in various jurisdictions around the world, including Europe, Japan, China, and South Korea
He engages quickly with clients on both the technical and legal issues that arise in IP matters across a broad range of technologies, including biologics, small molecule pharmaceuticals, gene editing, computer technology, and medical devices. Dr. Yue routinely provides analysis in anticipation of litigation and IP due diligence in the context of larger transactions.
Dr. Yue maintains an active pro bono practice, including immigration asylum cases and predatory housing matters.
Before practicing law, Dr. Yue earned a doctorate in immunology and holds a US patent based on his graduate research on the mammalian TRAIL receptor.
He served as a law clerk to the late Judge Robert W. Sweet of the Southern District of New York.